DEBORAH CAPUTO: Open Payments
NPI 1013105634 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 38 payments from 9 companies in 2025. Trend: 2023 $669 · 2024 $1,268 · 2025 $824
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $247 |
| Amneal Pharmaceuticals LLC | 23 | $228 |
| Medtronic, Inc. | 3 | $104 |
| InSightec,Inc | 1 | $93 |
| MDD US Operations, LLC | 4 | $74 |
| Janssen Biotech, Inc. | 1 | $25 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
| Solventum Corporation | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: General - DBS, CREXONT, PERCEPT PC BRAINSENSE, Exablate, Apokyn, TREMFYA, NUPLAZID, Xadago.
Industry payments across NJ — which companies pay providers there.
